✨ Your Portfolio is fetched and updated from zerodha.
Market Cap
₹2,101 Cr.
P/E
42.02
  • Vimta Labs
  • Krsnaa Diagnostics
  • Nidan Labs. & Health
  • TJI Pharma
FAQs on Vimta Labs Ltd. Shareprice

Vimta Labs has given better returns compared to its competitors.
Vimta Labs has grown at ~32.61% over the last 3yrs while peers have grown at a median rate of -8.05%

Yes, Vimta Labs is expensive.
Latest PE of Vimta Labs is 42.02, while 3 year average PE is 24.4.
Also latest EV/EBITDA of Vimta Labs is 20.71 while 3yr average is 11.16.

Growth Table
  • Vimta Labs Ltd.
  • Krsnaa Diagnostics
  • Nidan Labs. & Health
* Share price and PE growth are updated everyday. All other fields are as of latest financial year end. EPS adjusted for bonus and splits.
Balance Sheet
  • Vimta Labs Ltd.
  • Krsnaa Diagnostics
  • Nidan Labs. & Health
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Vimta Labs Ltd.
  • Krsnaa Diagnostics
  • Nidan Labs. & Health
TTM Values as of Sep 2024
Cash Flow
  • Vimta Labs Ltd.
  • Krsnaa Diagnostics
  • Nidan Labs. & Health
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Vimta Labs Ltd.
  • Krsnaa Diagnostics
  • Nidan Labs. & Health
Quarterly Results
  • Vimta Labs Ltd.
  • Krsnaa Diagnostics
  • Nidan Labs. & Health
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
50.10%
Implied Growth Rate over a 5 year period*
18.00%
Implied Growth Rate over a 10 year period*
8.50%
Implied Growth Rate over a 20 year period*
FAQs on Vimta Labs Ltd. Financials

Balance sheet of Vimta Labs is strong.
It shouldn't have solvency or liquidity issues.

Yes, The debt of Vimta Labs is increasing.
Latest debt of Vimta Labs is -₹16.17 Crs as of Sep-24.
This is greater than Mar-24 when it was -₹32.14 Crs.

The profit is oscillating.
The profit of Vimta Labs is ₹50.01 Crs for TTM, ₹41.01 Crs for Mar 2024 and ₹48.17 Crs for Mar 2023.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Vimta Labs latest dividend payout ratio is 10.81% and 3yr average dividend payout ratio is 10.23%

Companies resources are allocated to majorly unproductive assets like Capital Work in Progress

Data feed provided by Accord Fintech